85 Results

People

  1. Drilon
    Drilon
  2. Liu
    Liu
  3. Murciano-Goroff
    Murciano-Goroff
  4. Rosen
    Rosen
  5. Sherman
    Sherman
  6. Wilhelm
    Wilhelm
  7. Arcila
    Arcila
  8. Chang
    Chang
  9. Falcon
    Falcon
  10. Ladanyi
    Ladanyi

Groups

  1. Department of Medicine (85)
  2. Solid Tumor Oncology Division (85)
  3. Thoracic Oncology (85)
  4. GSK Faculty (18)
  5. Human Oncology and Pathogenesis Program (17)
  6. Graduate Medical Education (16)
  7. GME, Medicine (14)
  8. Tow Center for Developmental Oncology (TCDO) (12)
  9. Sloan Kettering Institute Postdocs (11)
  10. Epidemiology and Biostatistics (10)
  1. "Alexander Drilon"
  2. "Thoracic Oncology"
  3. "2022"
Formats
  1. Meeting Abstract (50)
  2. Journal Article (30)
  3. Review (3)
  4. Editorial (2)
Groups
  1. Department of Medicine (85)
  2. Solid Tumor Oncology Division (85)
  3. Thoracic Oncology (85)
  4. GSK Faculty (18)
  5. Human Oncology and Pathogenesis Program (17)
  6. Graduate Medical Education (16)

More Groups

People
  1. Alexander Drilon (85)
  2. Marc Ladanyi (10)
  3. Christina Falcon (8)
  4. Dazhi Liu (8)
  5. Guilherme Harada (8)
  6. Yonina Murciano-Goroff (8)

More People

Years
  1. 2022 (85)
Publications
  1. Journal of Clinical Oncology (18)
  2. Annals of Oncology (11)
  3. Cancer Research (5)
  4. Journal of Thoracic Oncology (5)
  5. JCO Precision Oncology (4)
  6. Neuro-Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Oxford University Press (15)
  3. Elsevier Inc. (13)
  4. American Association for Cancer Research (11)
  5. Nature Publishing Group (7)
  6. S. Karger AG (4)

More Publishers

Results (85)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selpercatinib-induced hypothyroidism through off-target inhibition of type 2 iodothyronine deiodinase
    Journal Article

    Boucai, L.; Salas-Lucia, F.; Krishnamoorthy, G. P.; Sherman, E.; Rudin, C. M.; Drilon, A.; Bianco, A. C.; Fagin, J. A.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Variability in NTRK gene fusions does not appear to impact response to larotrectinib
    Meeting Abstract

    Ladanyi, M.; Roy-Chowdhuri, S.; Ritterhouse, L.; Sahm, F.; Norenberg, R.; Shen, K.; Chen, C.; Fellous, M.; Brega, N.; van Tilburg, C. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The preclinical selectivity and activity of APS03118, a highly selective and potent next-generation RET inhibitor
    Meeting Abstract

    Drilon, A.; Zhong, J.; Lu, Y.; Liu, Y.; Wang, H.; Chen, M.; Chen, X.; Zhu, J.; Lu, S.; Subbiah, V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization
    Meeting Abstract

    Harada, G.; Falcon, C. J.; Santini, F. C.; Chang, J. C.; Yang, S. R.; Arcila, M. E.; Rekhtman, N.; Drilon, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • OncoKB, MSK's precision oncology knowledge base
    Meeting Abstract

    Suehnholz, S. P.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; Ladanyi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial
    Meeting Abstract

    Kroiss, M.; Sherman, E.; Wirth, L. J.; Cabanillas, M. E.; Robinson, B.; Subbiah, V.; Drilon, A.; Godbert, Y.; Fasnacht, N.; Soldatenkova, V.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours
    Meeting Abstract

    Shen, L.; Hong, D. S.; Tahara, M.; Baik, C. S.; Bauman, J. R.; Gilbert, J.; Brose, M. S.; Grilley-Olson, J. E.; Patil, T.; McDermott, R. S.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save